Insider filing · SRZN

Tim Kutzkey bought $4.0M of Surrozen (SRZN)

Executed Nov 13 2025, disclosed Dec 3 2025, 19 days later, against a two-business-day limit.

Over the 21 trading sessions from the disclosed entry session (Dec 2 2025), the stock returned +40.9% (delay-adjusted); from the execution session (Nov 13 2025), +84.7%. Derived: entry at the session's open, exit at the close 20 sessions later.

TK Tim Kutzkey Director profile →

Tim Kutzkey (Director) filed 5 Form 4 reports in the trailing twelve months (5 purchases, 0 sales, 1 filed past the two-business-day deadline), most often in Surrozen, Inc. (SRZN). Across 5 priced purchase filings, the average 21-session return was +35.4% from execution and +20.0% from disclosure (delay-adjusted; derived). The largest single filing was $4.0M of SRZN (315,457 sh across 2 lots, as filed), executed Nov 13 2025.

SRZN Surrozen, Inc. SRZN · Healthcare · 16 filings in 24 months ticker →

Healthcare · Surrozen, Inc., a biotechnology company, discovers and develops product candidates to selectively modulate the Wnt pathway for tissue repair

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→